The partnership will combine GSK and PathAI’s AI and platform engineering teams to scale algorithm development and enable the discovery of new insights that can be rapidly integrated into clinical trials.
The promise and challenges of relying on AI for drug development stanford.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stanford.edu Daily Mail and Mail on Sunday newspapers.
Computational biology particularly via combined HPC and AI has taken the spotlight during the pandemic as pharmaceutical companies and research institutes